Atlas Trials

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Clinical trial NCT07570810 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07570810
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Start date
2026-06-01
Primary completion
2026-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.